1. Home
  2. PGY vs NBTX Comparison

PGY vs NBTX Comparison

Compare PGY & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pagaya Technologies Ltd.

PGY

Pagaya Technologies Ltd.

HOLD

Current Price

$15.28

Market Cap

971.3M

Sector

Finance

ML Signal

HOLD

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

HOLD

Current Price

$45.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGY
NBTX
Founded
2016
2003
Country
United States
France
Employees
518
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
971.3M
1.0B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
PGY
NBTX
Price
$15.28
$45.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
1
Target Price
$34.50
$36.00
AVG Volume (30 Days)
3.4M
56.8K
Earning Date
05-07-2026
03-31-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.27
$58.17
Revenue Next Year
$14.39
N/A
P/E Ratio
$13.54
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.40
$3.64
52 Week High
$44.99
$44.46

Technical Indicators

Market Signals
Indicator
PGY
NBTX
Relative Strength Index (RSI) 63.10 72.20
Support Level $10.78 $20.11
Resistance Level $15.57 N/A
Average True Range (ATR) 0.87 2.08
MACD 0.12 1.20
Stochastic Oscillator 56.18 99.80

Price Performance

Historical Comparison
PGY
NBTX

About PGY Pagaya Technologies Ltd.

Pagaya Technologies Ltd is a product-focused technology company. It uses machine learning, a vast data network, and an AI-driven approach to offer comprehensive consumer credit and residential real estate products for its partners, their customers, and investors. Its suite of products includes Decline Monetization, Dual Look, First Look, Affiliate Optimizer Engine, Direct Marketing Engine, and FastPass, providing lenders with an AI-powered credit and acquisition ecosystem that helps them approve more borrowers, capture more demand, and grow without adding risk. Geographically, the company generates maximum revenue from its business in the United States.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: